J2 Global Offers Free Patient Record Query Through Consensus Interoperability Platform During COVID-19 Crisis
J2 Global, Inc. (@j2global), an Internet and information services company, announced that it will offer healthcare providers free access to on-demand patient record query during the COVID-19 crisis through its recently introduced Consensus healthcare interoperability platform. On-demand record query is a valuable tool within Consensus that enables healthcare providers to access patient records needed for treatment through Carequality.
Health Scholars Announces a $1M in grant funding for surge provider training to help combat COVID-19
Health Scholars (@HealthScholars1), the creator of the first ever virtual reality (VR) Advanced Cardiac Life Support (ACLS) training announces a $1M in grant funding for surge provider training to help combat COVID-19.
Global Cannabinoids Receives over $15 Million in Hand Sanitizer Orders in the Past 7 Days as the Company Builds the Largest Ethanol to Sanitizer Supply Chain in the USA
Global Cannabinoids (@global_canna), and its newly formed entity, Global Sanitizers LLC, is pleased to announce that it has secured over $15 Million Dollars in hand sanitizer orders in the past week as the company continues to position itself as the leading bulk and wholesale supplier of hand sanitizers in the USA. Global Cannabinoids, the leading US producer, manufacturer, and distributor of hemp derived cannabinoids, has shifted its vast supply chain of ethanol used in the extraction of hemp, toward the production of hand sanitizers to meet the growing demand for these ethanol alcohol based products. In order to accomplish this, the company has secured the delivery of hundreds of thousands of gallons of 40-B and 3-C denatured ethanol, approved by the FDA for topical use, toward the largest OTC manufacturers of hand sanitizers in the US.
RxSafe LLC Launches ViralGuardRx COVID-19 Protection
As coronavirus cases surge nationwide, retail pharmacies are facing incredibly difficult circumstances: they must continue to dispense vital medications to their patients, and fight the spread of COVID-19 — while keeping both employees and patients as safe as possible. To address this challenge, RxSafe LLC (@RxSafe) launched ViralGuardRx™, a protective shield that creates a physical barrier to help prevent disease transmission at the pharmacy point-of-sale. Placed at pharmacy cash registers or pickup locations, ViralGuardRx helps reduce the risk of viral and bacterial transmission, protecting pharmacy staff and consumers from the spread of coronavirus.
EpiGentek announces a new antibody-based blood test to detect COVID-19 in as little as 3 minutes
EpiGentek (@epigentek), a NY-based biotechnology firm specializing in epigenetic assay products and services, has announced that in light of the ongoing COVID-19 global pandemic, it is launching a rapid serological test to detect for the disease. The method uses blood samples such as fingertip blood and can deliver results in under 15 minutes and as fast as 3 minutes. The company, known for its fast and easy antibody-based assays, recently sent to the FDA a notice of intent to distribute the kits and expects full availability in mid-April.
Cloud-based electronic system may help first responders better react to natural disasters
Purdue University researchers have developed a new tool to help first responders and disaster relief organizations better provide assistance to developing countries. The Purdue team created a cloud-based supply chain management system for emergency response to track inventory and distribution in countries struck by disasters.
New Analytic-Powered COVID-19 Calculator Estimates Medical Costs
Care Bridge International (@CareBridgeIntl), a data analytics corporation, announced a new COVID-19 Calculator that estimates the true exposure of medical treatment and costs related to COVID-19 claims. As a public service during this difficult time, Care Bridge International is offering a FREE interactive tool at https://www.AnalyticPoweredCOVID19.com for businesses who need to understand the average medical costs associated with a COVID-19 diagnosis for a Workers Compensation claim, Group health or General Liability claims or the costs for Medicare beneficiaries.
Caris Life Sciences Launches MI FOLFOXai, Improving Overall Survival by 50% for Metastatic Colorectal Cancer Patients
Caris Life Sciences (@carisls), an innovator in molecular science focused on fulfilling the promise of precision medicine, announced the launch of MI FOLFOXai™, the newest addition to the company’s suite of comprehensive molecular science offerings. MI FOLFOXai is an Artificial Intelligence (AI)-based predictor of response to FOLFOX chemotherapy in metastatic colorectal cancer that demonstrated approximately 50 percent improvement in overall survival across two independent validation studies. Using Caris Molecular Intelligence® tumor profiling results, this AI-powered predictor is intended to gauge a patient’s likelihood of benefit from FOLFOX as a first-line regimen in combination with bevacizumab.
VisitPay Report: Cost Is #1 Driver of Provider Choice
VisitPay (@visitpay), a patient financial engagement company, has released its second annual study of the patient as payer. Additionally, VisitPay announced the addition of two senior executives to its leadership team: David P. Smith has joined as chief technology officer (CTO) and Tom Ryden has joined as chief financial officer (CFO). Both bring extensive experience and success in growth stage companies which will support VisitPay’s consistent year-over-year expansion.
RLDatix Acquires Transparent Health Consulting; Appoints Patient Safety & Risk Management Expert Dr. Tim McDonald to Executive Team
RLDatix (@rldatix), a global provider of intelligent patient safety solutions, announced that it has acquired Transparent Health Consulting, a firm that focuses on the implementation of communication and patient safety resolution programs in order to respond to and prevent patient harm.
Usage of Telehealth and Retail Clinics Grew from 2017 to 2018 While That of ERs, ASCs and Urgent Care Declined
From 2017 to 2018, telehealth use grew 12 percent and use of retail clinics grew 10 percent, but use of urgent care centers, ambulatory surgery centers (ASCs) and emergency rooms (ERs) all declined, according to newly released findings from FAIR Health. Urgent care center use fell 11 percent, ASC use fell 12 percent and ER use fell 15 percent. These are among the findings in a new FAIR Health (@fairhealth) white paper containing the third annual edition of FH® Healthcare Indicators and FH® Medical Price Index.